
|Videos|November 25, 2021
JAK Inhibitors: Drilling Down the Details
Author(s)Mary Scoviak, Managing Editor
In this exclusive video interview, James Q Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the headlines around the treatments.
Advertisement
James Q Del Rosso, DO, Research Director of JDR Dermatology Research in Las Vegas, Nevada and Senior Vice President of Clinical Research and Strategic Development at Advanced Dermatology & Cosmetic Surgery in Maitland, Florida, sits down with Dermatology Times® to highlight why JAK inhibitors work the way they do, how they differ from other inhibitors, and more.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















